UEG Week 2024

IF 45.9 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Katrina Ray
{"title":"UEG Week 2024","authors":"Katrina Ray","doi":"10.1038/s41575-024-01013-z","DOIUrl":null,"url":null,"abstract":"<p>From 12–15 October, United European Gastroenterology (UEG) Week was held in person in Vienna, Austria, and online simultaneously. According to the organizers, there were 11,377 total registrants from 114 countries or territories, of whom 11% were registered for the virtual congress, with 4,701 individuals registered for the Postgraduate Teaching Programme, of whom 19% were registered for virtual attendance.</p><p>Alongside the usual variety of sessions on basic, translational and clinical science across the fields of gastroenterology and hepatology, there was an expansion in the scope of the topics covered, and indeed how they were delivered (so-called silent sessions with attendees listening on headphones). Sessions on metabolism and nutrition were noticeably prominent, highlighting the current interest in food as medicine and the new obesity management medications. A whole session was dedicated to the role of nutrition in the pathogenesis and treatment of lower gastrointestinal disease and a late-breaker abstract presented positive data for the ‘Tasty&amp;Healthy’ flexible diet in children and young adults with mild–moderate Crohn’s disease. Attendees were also guided through the underlying mechanisms for GLP1 agonists and the ever-expanding list of dual and triple agonists for the management of obesity, as well as given practical advice on the therapeutic management of obesity, which included lifestyle interventions and surgery.</p>","PeriodicalId":18793,"journal":{"name":"Nature Reviews Gastroenterology &Hepatology","volume":"125 1","pages":""},"PeriodicalIF":45.9000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews Gastroenterology &Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41575-024-01013-z","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

From 12–15 October, United European Gastroenterology (UEG) Week was held in person in Vienna, Austria, and online simultaneously. According to the organizers, there were 11,377 total registrants from 114 countries or territories, of whom 11% were registered for the virtual congress, with 4,701 individuals registered for the Postgraduate Teaching Programme, of whom 19% were registered for virtual attendance.

Alongside the usual variety of sessions on basic, translational and clinical science across the fields of gastroenterology and hepatology, there was an expansion in the scope of the topics covered, and indeed how they were delivered (so-called silent sessions with attendees listening on headphones). Sessions on metabolism and nutrition were noticeably prominent, highlighting the current interest in food as medicine and the new obesity management medications. A whole session was dedicated to the role of nutrition in the pathogenesis and treatment of lower gastrointestinal disease and a late-breaker abstract presented positive data for the ‘Tasty&Healthy’ flexible diet in children and young adults with mild–moderate Crohn’s disease. Attendees were also guided through the underlying mechanisms for GLP1 agonists and the ever-expanding list of dual and triple agonists for the management of obesity, as well as given practical advice on the therapeutic management of obesity, which included lifestyle interventions and surgery.

UEG 2024 周
10 月 12 日至 15 日,欧洲联合肠胃病学周(UEG)在奥地利维也纳以现场和在线方式同时举行。据主办方称,共有来自114个国家或地区的11,377人注册,其中11%注册了虚拟大会,4,701人注册了研究生教学计划,其中19%注册了虚拟参会。除了胃肠病学和肝脏病学领域的基础、转化和临床科学方面的常规会议外,会议主题的范围也有所扩大,而且会议方式也有所改变(所谓的无声会议,与会者戴耳机聆听)。有关新陈代谢和营养的会议明显突出,凸显了当前人们对食物即药物和新型肥胖症治疗药物的兴趣。整场会议专门讨论了营养在下消化道疾病的发病机制和治疗中的作用,会议后期发表的一篇摘要介绍了 "Tasty&Healthy "灵活饮食对轻中度克罗恩病儿童和年轻人的积极作用。与会者还了解了 GLP1 激动剂的基本机制以及用于治疗肥胖症的不断扩大的双重和三重激动剂列表,并获得了关于肥胖症治疗管理的实用建议,其中包括生活方式干预和手术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
52.30
自引率
0.60%
发文量
147
审稿时长
6-12 weeks
期刊介绍: Nature Reviews Gastroenterology & Hepatology aims to serve as the leading resource for Reviews and commentaries within the scientific and medical communities it caters to. The journal strives to maintain authority, accessibility, and clarity in its published articles, which are complemented by easily understandable figures, tables, and other display items. Dedicated to providing exceptional service to authors, referees, and readers, the editorial team works diligently to maximize the usefulness and impact of each publication. The journal encompasses a wide range of content types, including Research Highlights, News & Views, Comments, Reviews, Perspectives, and Consensus Statements, all pertinent to gastroenterologists and hepatologists. With its broad scope, Nature Reviews Gastroenterology & Hepatology ensures that its articles reach a diverse audience, aiming for the widest possible dissemination of valuable information. Nature Reviews Gastroenterology & Hepatology is part of the Nature Reviews portfolio of journals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信